FierceBiotech 6 avr. 2026 Anthropic acquires stealth AI startup Coefficient Bio in $400M deal: reports
FierceBiotech 6 avr. 2026 Buoyed by $100M Series A, Stipple Bio debuts to advance lead oncology asset into clinic
FierceBiotech 4 avr. 2026 White House floats 12.5% budget cut for HHS in FY2027, reiterates reorganization plan
FierceBiotech 3 avr. 2026 ADCs, TCEs among ‘exciting things’ on Boehringer’s dealmaking shopping list
FierceBiotech 3 avr. 2026 Months after $100M series A, Syneron closes $150M round to support peptide platform
FierceBiotech 2 avr. 2026 UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments
FierceBiotech 2 avr. 2026 Epia Neuro launches with BCI device to help stroke patients rework brain signals
FierceBiotech 2 avr. 2026 Immunovant’s FcRn inhibitor flunks phase 3 eye disease trials, validating biotech’s waning interest